Overview

Bioavailability Study of Clonazepam ODT Under Fasting Conditions

Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
To compare the single-dose bioavailability of Clonazepam ODT 1 mg and Klonopin Wafers 1 mg ODT
Phase:
Phase 1
Details
Lead Sponsor:
Par Pharmaceutical, Inc.
Collaborators:
Cetero Research, San Antonio
Gatway Medical Research, Inc
Treatments:
Clonazepam